AU2007214120A1 - Calving characteristics - Google Patents
Calving characteristics Download PDFInfo
- Publication number
- AU2007214120A1 AU2007214120A1 AU2007214120A AU2007214120A AU2007214120A1 AU 2007214120 A1 AU2007214120 A1 AU 2007214120A1 AU 2007214120 A AU2007214120 A AU 2007214120A AU 2007214120 A AU2007214120 A AU 2007214120A AU 2007214120 A1 AU2007214120 A1 AU 2007214120A1
- Authority
- AU
- Australia
- Prior art keywords
- region
- genetic marker
- markers
- genetic
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003550 marker Substances 0.000 claims description 775
- 230000002068 genetic effect Effects 0.000 claims description 703
- 241000283690 Bos taurus Species 0.000 claims description 450
- 210000000349 chromosome Anatomy 0.000 claims description 436
- 238000000034 method Methods 0.000 claims description 112
- 208000002254 stillbirth Diseases 0.000 claims description 94
- 231100000537 stillbirth Toxicity 0.000 claims description 94
- 108091092878 Microsatellite Proteins 0.000 claims description 67
- 244000309466 calf Species 0.000 claims description 49
- 108091034117 Oligonucleotide Proteins 0.000 claims description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 10
- 238000009007 Diagnostic Kit Methods 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 description 71
- 230000008774 maternal effect Effects 0.000 description 43
- 239000002773 nucleotide Substances 0.000 description 43
- 125000003729 nucleotide group Chemical group 0.000 description 43
- 108090000623 proteins and genes Proteins 0.000 description 40
- 230000000694 effects Effects 0.000 description 35
- 150000007523 nucleic acids Chemical class 0.000 description 22
- 239000013615 primer Substances 0.000 description 21
- 108020004707 nucleic acids Proteins 0.000 description 19
- 102000039446 nucleic acids Human genes 0.000 description 19
- 239000000523 sample Substances 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 17
- 238000009396 hybridization Methods 0.000 description 13
- 230000003321 amplification Effects 0.000 description 12
- 238000003199 nucleic acid amplification method Methods 0.000 description 12
- 230000004983 pleiotropic effect Effects 0.000 description 12
- 238000001514 detection method Methods 0.000 description 11
- 238000003752 polymerase chain reaction Methods 0.000 description 11
- 230000035772 mutation Effects 0.000 description 10
- 108700028369 Alleles Proteins 0.000 description 9
- 230000000295 complement effect Effects 0.000 description 9
- 101100022971 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SAM1 gene Proteins 0.000 description 8
- 102000054765 polymorphisms of proteins Human genes 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 6
- 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 230000001488 breeding effect Effects 0.000 description 6
- 235000013365 dairy product Nutrition 0.000 description 6
- 238000013507 mapping Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000042032 Petrocephalus catostoma Species 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 102000054766 genetic haplotypes Human genes 0.000 description 4
- 238000001558 permutation test Methods 0.000 description 4
- 239000002987 primer (paints) Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- WGLMBRZXZDAQHP-UHFFFAOYSA-N BMS 195614 Chemical compound C=1C=C2C(C)(C)CC=C(C=3C=C4C=CC=CC4=NC=3)C2=CC=1C(=O)NC1=CC=C(C(O)=O)C=C1 WGLMBRZXZDAQHP-UHFFFAOYSA-N 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 108091093037 Peptide nucleic acid Proteins 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 239000010902 straw Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 2
- 238000012252 genetic analysis Methods 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 235000003930 Aegle marmelos Nutrition 0.000 description 1
- 244000058084 Aegle marmelos Species 0.000 description 1
- 241001133287 Artocarpus hirsutus Species 0.000 description 1
- 241000030939 Bubalus bubalis Species 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 101100229963 Drosophila melanogaster grau gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 101100435070 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) APN2 gene Proteins 0.000 description 1
- 101100268779 Solanum lycopersicum ACO1 gene Proteins 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000012248 genetic selection Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 244000309465 heifer Species 0.000 description 1
- 101150032210 hel-1 gene Proteins 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002966 oligonucleotide array Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000001869 rapid Effects 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000000123 temperature gradient gel electrophoresis Methods 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200600181 | 2006-02-08 | ||
| DKPA200600181 | 2006-02-08 | ||
| DKPA200700165 | 2007-01-31 | ||
| DKPA200700165 | 2007-01-31 | ||
| PCT/DK2007/000060 WO2007090401A2 (en) | 2006-02-08 | 2007-02-05 | Calving characteristics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2007214120A1 true AU2007214120A1 (en) | 2007-08-16 |
Family
ID=37946083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007214120A Abandoned AU2007214120A1 (en) | 2006-02-08 | 2007-02-06 | Calving characteristics |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090181386A1 (enExample) |
| EP (1) | EP2032717A2 (enExample) |
| JP (1) | JP2009525734A (enExample) |
| AR (1) | AR059367A1 (enExample) |
| AU (1) | AU2007214120A1 (enExample) |
| WO (1) | WO2007090401A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107760789B (zh) * | 2017-09-18 | 2021-03-02 | 中国农业科学院兰州畜牧与兽药研究所 | 一种用于牦牛亲子鉴定和个体识别的基因分型检测试剂盒 |
| AU2023250649A1 (en) | 2022-04-04 | 2024-11-14 | The Regents Of The University Of California | Genetic complementation compositions and methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| WO1992013102A1 (en) * | 1991-01-15 | 1992-08-06 | Genmark | Polymorphic dna markers in bovidae |
-
2007
- 2007-02-05 WO PCT/DK2007/000060 patent/WO2007090401A2/en not_active Ceased
- 2007-02-05 US US12/223,773 patent/US20090181386A1/en not_active Abandoned
- 2007-02-06 AU AU2007214120A patent/AU2007214120A1/en not_active Abandoned
- 2007-02-06 EP EP07702478A patent/EP2032717A2/en not_active Withdrawn
- 2007-02-06 JP JP2008553617A patent/JP2009525734A/ja not_active Withdrawn
- 2007-02-08 AR ARP070100524A patent/AR059367A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20090181386A1 (en) | 2009-07-16 |
| AR059367A1 (es) | 2008-03-26 |
| JP2009525734A (ja) | 2009-07-16 |
| EP2032717A2 (en) | 2009-03-11 |
| WO2007090401A3 (en) | 2007-11-08 |
| WO2007090401A2 (en) | 2007-08-16 |
| WO2007090401A8 (en) | 2008-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2010065470A2 (en) | Compositions and methods for detecting background male dna during fetal sex determination | |
| AU2009275988B2 (en) | A genetic marker test for Brachyspina and fertility in cattle | |
| US20100323349A1 (en) | Identification of the Gene and Mutation Responsible for Progressive Rod-Cone Degeneration in Dog and a Method for Testing Same | |
| JP4130125B2 (ja) | 牛における複合脊椎奇形キャリアーを同定するための遺伝試験 | |
| US20100003675A1 (en) | Qtls for Mastitis Resistance in Cattle | |
| US20090181386A1 (en) | Calving Characteristics | |
| US20090176224A1 (en) | Udder Health Characteristics | |
| WO2008014550A1 (en) | Markers for pigmentation | |
| TW201311908A (zh) | 診斷犬之青光眼的方法及套組 | |
| US10770183B2 (en) | Methods of assessing a risk of developing necrotizing meningoencephalitis | |
| US8124337B2 (en) | Hereditary cataract status in canines based on HSF4 gene marker | |
| WO2009097862A1 (en) | Genetic markers for fertility | |
| CA2647224C (en) | Identification of a novel gene underlying familial spastic paraplegia | |
| WO2010108498A1 (en) | Genetic markers for mastitis resistance | |
| KR102336624B1 (ko) | 돈육의 콜라겐 함량 예측용 마커 및 이의용도 | |
| EP2707497A1 (en) | Detecting the brachyspina mutation | |
| US20080118914A1 (en) | Follistatin gene as a genetic marker for first parity litter size in pigs | |
| CN101415842A (zh) | 牛乳房炎抗性的qtl | |
| JP3948702B2 (ja) | ウシのＣｌａｕｄｉｎ−１６欠損症タイプ２の遺伝子診断法 | |
| CN101415840A (zh) | 产犊特征 | |
| AU2007281024B2 (en) | Markers for pigmentation | |
| WO2015129018A1 (ja) | イヌの緑内障を診断する方法及びキット | |
| WO2009142474A1 (en) | Genetic markers predicting age at menopause | |
| JP2001333799A (ja) | 骨粗鬆症薬剤感受性予測方法およびそのための試薬キット | |
| WO2010008809A2 (en) | Compositions and methods for early stage sex determination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ FROM MAJGREN, BENTE FLUGEL TO MAJGREN, BENTE FLUEGEL |
|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |